» Articles » PMID: 38696595

Quantitative Proteomics of Dorsolateral Prefrontal Cortex Reveals an Early Pattern of Synaptic Dysmaturation in Children with Idiopathic Autism

Overview
Journal Cereb Cortex
Specialty Neurology
Date 2024 May 2
PMID 38696595
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorder (ASD) is a developmental disorder with a rising prevalence and unknown etiology presenting with deficits in cognition and abnormal behavior. We hypothesized that the investigation of the synaptic component of prefrontal cortex may provide proteomic signatures that may identify the biological underpinnings of cognitive deficits in childhood ASD. Subcellular fractions of synaptosomes from prefrontal cortices of age-, brain area-, and postmortem-interval-matched samples from children and adults with idiopathic ASD vs. controls were subjected to HPLC-tandem mass spectrometry. Analysis of data revealed the enrichment of ASD risk genes that participate in slow maturation of the postsynaptic density (PSD) structure and function during early brain development. Proteomic analysis revealed down regulation of PSD-related proteins including AMPA and NMDA receptors, GRM3, DLG4, olfactomedins, Shank1-3, Homer1, CaMK2α, NRXN1, NLGN2, Drebrin1, ARHGAP32, and Dock9 in children with autism (FDR-adjusted P < 0.05). In contrast, PSD-related alterations were less severe or unchanged in adult individuals with ASD. Network analyses revealed glutamate receptor abnormalities. Overall, the proteomic data support the concept that idiopathic autism is a synaptopathy involving PSD-related ASD risk genes. Interruption in evolutionarily conserved slow maturation of the PSD complex in prefrontal cortex may lead to the development of ASD in a susceptible individual.

Citing Articles

A most important gift: the critical role of postmortem brain tissue in autism science.

Natowicz M, Bauman M, Edelson S Front Neurol. 2024; 15:1486227.

PMID: 39726759 PMC: 11670190. DOI: 10.3389/fneur.2024.1486227.


Heterogeneity and convergence across seven neuroimaging modalities: a review of the autism spectrum disorder literature.

Halliday A, Vucic S, Georges B, LaRoche M, Mendoza Pardo M, Swiggard L Front Psychiatry. 2024; 15:1474003.

PMID: 39479591 PMC: 11521827. DOI: 10.3389/fpsyt.2024.1474003.

References
1.
Gandal M, Haney J, Wamsley B, Yap C, Parhami S, Emani P . Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD. Nature. 2022; 611(7936):532-539. PMC: 9668748. DOI: 10.1038/s41586-022-05377-7. View

2.
Sabo S, Lahr J, Offer M, Weekes A, Sceniak M . -related neurodevelopmental disorder: current understanding of pathophysiological mechanisms. Front Synaptic Neurosci. 2023; 14:1090865. PMC: 9873235. DOI: 10.3389/fnsyn.2022.1090865. View

3.
Jung S, Park M . Shank postsynaptic scaffolding proteins in autism spectrum disorder: Mouse models and their dysfunctions in behaviors, synapses, and molecules. Pharmacol Res. 2022; 182:106340. DOI: 10.1016/j.phrs.2022.106340. View

4.
Sala C, Vicidomini C, Bigi I, Mossa A, Verpelli C . Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. J Neurochem. 2015; 135(5):849-58. DOI: 10.1111/jnc.13232. View

5.
Soler J, Fananas L, Parellada M, Krebs M, Rouleau G, Fatjo-Vilas M . Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review. J Psychiatry Neurosci. 2018; 43(4):223-244. PMC: 6019351. DOI: 10.1503/jpn.170066. View